ALNY Market Cap History
Below is a table of the ALNY market cap history going back to 1/31/2010:

Date ALNY Market Cap
1/31/2010707.05M
4/30/2010711.66M
7/30/2010646.18M
10/29/2010554.51M
1/31/2011437.41M
5/2/2011424.08M
7/29/2011400.07M
10/31/2011346.94M
1/31/2012499.49M
4/30/2012591.71M
7/31/2012976.46M
10/31/2012847.54M
1/31/20131.49B
4/30/20131.49B
7/31/20132.91B
10/31/20133.65B
1/31/20145.35B
4/30/20143.74B
7/31/20144.13B
10/31/20147.13B
1/30/20157.86B
4/30/20158.59B
7/31/201510.78B
10/30/20157.28B
1/29/20165.87B
4/29/20165.74B
7/29/20165.84B
10/31/20163.05B
1/31/20173.44B
4/28/20174.62B
7/31/20177.59B
10/31/201711.30B
1/31/201812.98B
4/30/20189.50B
7/31/20189.56B
10/31/20188.13B
1/31/20198.88B
4/30/20199.52B
7/31/20198.63B
10/25/20199.95B
2/7/202014.13B
4/30/202015.12B
7/31/202016.90B
10/30/202014.29B
2/5/202119.32B
4/23/202116.07B
7/30/202121.27B
10/22/202123.75B
2/4/202217.48B
4/22/202220.18B
7/22/202217.19B

Also see: ALNY Shares Outstanding History
and ALNY YTD Return
ALNY Historical Market Cap:
+29.14% CAGR
ALNY Historical Market Cap: +29.14% CAGR

Mouse over chart for data details
1/31/2010 ...7/22/2022
Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. We show 51 historical shares outstanding datapoints in our ALNY shares outstanding history coverage, used to compute ALNY market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ALNY market cap history over the course of time is important for investors interested in comparing ALNY's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ALNY versus a peer is one thing; comparing ALNY market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ALNY can fluctuate over the course of history. With this page we aim to empower investors researching ALNY by allowing them to research the ALNY market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ALNY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Alnylam Pharmaceuticals (ALNY) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ALOG Market Cap History
ALPN Market Cap History
ALQA Market Cap History
ALRN Market Cap History
ALT Market Cap History
ALVR Market Cap History
ALXN Market Cap History
ALXO Market Cap History
ALZN Market Cap History
AMAG Market Cap History
More Healthcare companies »

 

ALNY Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.